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Available online 6 May 2016Background: Peripheral blood leukocytes are the most commonly used surrogates to study epigenome-induced
risk and epigenomic response to disease-related stress. We considered the hypothesis that the various classes
of peripheral leukocytes differentially regulate the synthesis of 5-methylcytosine (5mCG) and its removal via
Ten-Eleven Translocation (TET) dioxygenase catalyzed hydroxymethylation to 5-hydroxymethylcytosine
(5hmCG), reﬂecting their responsiveness to environment. Although it is known that reductions in TET1 and/or
TET2 activity lead to the over-proliferation of various leukocyte precursors in bone marrow and in development
of chronic myelomonocytic leukemia and myeloproliferative neoplasms, the role of 5mCG hydroxymethylation
in peripheral blood is less well studied.
Results:We developed simpliﬁed protocols to rapidly and reiteratively isolate non-overlapping leukocyte popu-
lations from a single small sample of fresh or frozen whole blood. Among peripheral leukocyte types we found
extreme variation in the levels of transcripts encoding proteins involved in cytosine methylation (DNMT1, 3A,
3B), the turnover of 5mC by demethylation (TET1, 2, 3), and DNA repair (GADD45A, B, G) and in the global
and gene-region-speciﬁc levels of DNA 5hmCG (CD4+ T cells ≫ CD14+ monocytes N CD16+
neutrophils N CD19+ B cells N CD56+ NK cells N Siglec8+ eosinophils N CD8+ T cells).
Conclusions:Our data taken together suggest a potential hierarchy of responsiveness among classes of leukocytes
with CD4+, CD8+ T cells and CD14+ monocytes being the most distinctly poised for a rapid methylome re-
sponse to physiological stress and disease.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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. This is an open access article under1. Background
Peripheral blood leukocytes are the most commonly used cell types
to assess human disease states (Javierre et al., 2010; Huang et al., 2014;
Di Francesco et al., 2015; Ellinger et al., 2015). Because of their accessi-
bility, leukocytes are used in preference to other tissues such as the
brain, muscle, adipose tissue, bone or various non-blood-borne cancer
cells, even when these latter cell types are the focus of disease. As a re-
sult, the methylome and transcriptome of peripheral blood leukocytes
often act as proxies for disease states centered in other tissues and cell
types. One implicit assumption is that genetic and epigenetic
reprogramming caused by disease states in other tissues are systemical-
ly reﬂected in blood-borne leukocytes. There are numerous published
studies examining the response of genome-methylation in whole
blood leukocytes to diseases and disease progression (Javierre et al.,
2010; Wang et al., 2010; Weiss et al., 2011; Saied et al., 2012;
Schroeder et al., 2012; Smith et al., 2012, 2014; Sun et al., 2013; Xuthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The dynamic modiﬁcation cycle of DNA cytosine and its impact on gene activity. This
model of the turnover of modiﬁed cytosine (C) residues emphasizes the central role of
DNMTs in the methylation of C to 5-methylcytosine (5mC) and TETs in the rate limiting
removal of 5mC by oxidation to 5-hydroxymethylcytosine (5hmC). The dynamic turnover
of 5mC appears critical to regulating rapid changes in linked gene expression (Meagher,
2014; Wu and Zhang, 2014). TETs may further oxidize 5hmC to 5-formalcytosine (5fC)
and 5-carboxycytosine (5caC). Thymine DNA glycosidase TDG removes the modiﬁed 5fC
or 5caC bases leaving an abasic nucleotide (–OH). Base excision repair (BER) repairs the
single nucleotide gap in double stranded DNA back to a C residue. Enzymes are in square
boxes and nucleotide bases are in ovals. The diagram was modiﬁed from (Kohli and
Zhang, 2013), based on the data in (Chen et al., 2012; Ramon et al., 2012; Dubois-
Chevalier et al., 2014; Haseeb et al., 2014; Oger et al., 2014).
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tion data from these studies comprises the epigenomic information of
several major leukocyte cell types combined as a weighted average of
their fractional representation in blood.
Epigenetics, from its modern inception, predicts that different cell
types within a tissue or organ are epigenetically distinct (Nanney,
1958). Reinius et al. (2012) made pairwise comparisons of the
methylomes of seven major leukocyte types to reveal that even the
two most closely related peripheral blood mononuclear cells (PBMCs),
CD4+/CD8± and CD8+/CD4± T cells, differ signiﬁcantly in DNA
methylation levels. Over 45,000 of the 485,000 cysteine-guanine dinu-
cleotide (CG) sites measured (~9%), which are concentrated in gene re-
gions, are distinct. Equally remarkable, the PBMC CD8+ T cells and
granulocyte Siglec8+ eosinophils differ in approximately 193,000 of
the CG sites measured (~40%) (Reinius et al., 2012). Different leukocyte
types all have quantitatively different global methylation proﬁles, with
the relatively hypomethylated granulocytes (Siglec8+ eosinophils,
CD16+ neutrophils) showing 5 to 10 times less methylation across dif-
ferent gene regions than the hypermethylated PBMC lymphoid cell
types (CD4+ and CD8+ T cells, CD19+ B cells, CD56+ NK cells,
CD14+monocytes) (Reinius et al., 2012).When these cell types are an-
alyzed together inDNAmethylation studies using total peripheral blood
DNA, themethylation proﬁles from the seven leukocyte types with high
and low levels of methylation, as well as their sequence speciﬁc differ-
ences in methylation, are obscured as a weighted averaged depending
upon cell type frequency. Many statistically signiﬁcant differences in
the methylation proﬁles of individual cell types are lost, making the
results from whole blood less intelligible and less meaningful than
they would be from individual cell types.
In the Reinius et al. (2012) study they startedwith largewhole blood
samples, separated PBMCs and granulocytes by density centrifugation
on Ficoll-Paque gradients and lysed the remaining red blood cells with
NH4Cl. Seven leukocyte subtypes were then isolated from separate
aliquots of the PBMC and granulocyte fractions by immuno-
paramagnetic bead capture. Fluorescence activated multichannel cell
sorting (FACS) can also be used to isolate various classes of leukocytes
after Ficoll gradient separation (Roederer et al., 1997; Melzer et al.,
2015). Herein, as a potentially less expensive and rapid alternative to
these two methods we develop the approach of ﬁrst lysing red blood
cells by NH4Cl treatment or by freezing and thawing and then reitera-
tively isolating six or seven cell types on immuno-paramagnetic beads
starting from a single small starting sample. A reiterative approach
(Lyons et al., 2007) has the potential to eliminate or include speciﬁc
cell types expressing overlapping markers in each isolated class,
depending upon the order of isolation, and providing relatively pure
distinct leukocyte populations for subsequent epigenetic analysis. The
utility of examining non-overlapping populations of leukocytes is dem-
onstrated herein by our own analysis of 5hmCG levels and supports the
previous beneﬁts of reiterative methods presented in Lyons et al.
(2007).
Recent evidence suggests the gene sequence-speciﬁc differences in
5mCG levels at 20% of CG sites are tissue speciﬁc and may be important
to changes in gene regulation, whereas 80% of global 5mCGs appear to
have little impact on gene expression (Lister et al., 2013; Meagher,
2014; Wu and Zhang, 2014; Gu et al., 2016). By contrast, 5hmCG levels
are much lower than 5mCG levels, but highly correlated with differen-
tial gene regulation (Mellen et al., 2012; Lister et al., 2013; Tsagaratou
et al., 2014). 5hmCG is concentrated in euchromatin (Ficz, 2015),
which has an open-chromatin conformation facilitating transcriptional
regulation. Genes and gene regions enriched for 5hmCG are said to be
“poised” to be differentially regulated (Pastor et al., 2011). For example,
during chondrogenesis there is an increase in 5hmCG associated with
important chondrogenic genes, while minimal changes in 5hmCG
were observed in housekeeping genes (Taylor et al., 2016). Finally,
5hmCGenriched gene sets appear to be relatively distinct for each tissue
(Nestor et al., 2012). Therefore, it is reasonable to propose thatdifferences in gene region speciﬁc 5hmCG levels among peripheral
blood might reﬂect their potential to respond to their environment
with changes in gene expression.
We recently presented strong evidence that the majority of
functional 5mCG sites, turn over rapidly (Fig. 1), with half-lives of less
than an hour (Meagher, 2014). Many of the proteins essential to the es-
tablishment and maintenance of 5mCG (DNA methyltransferases,
DNMT1, DNMT3A, DNMT3B), removal of 5mCG by oxidation to
5hmCG (Ten eleven translocation dioxygenase, TET1, 2, 3), and repair
back to cytosine (Growth arrest and DNA damage induced, GADD45A,
B, G) are expressed in leukocytes (Calabrese et al., 2014). TET catalyzed
oxidation may be a rate-limiting step in 5mCG removal (Sabag et al.,
2014; Wu and Zhang, 2014), and hence, the model presented in Fig. 1
emphasizes the central importance of TET activity to the turnover of
modiﬁed cytosine and its potential impact on gene regulation.
There are limited data showing the importance of the DNA methyl-
ation cycle (Fig. 1) to peripheral blood leukocytes. TET enzyme oxida-
tion of 5mCG to 5hmCG is critical in T cell development as well as in
the expression of T cell lineage speciﬁc genes (Tsagaratou et al., 2014;
Ichiyama et al., 2015). RNAi mediated silencing of TET2 in cord blood
progenitor CD34+ cells lowers 5hmCG levels and skews differentiation
toward granulocytes and away from lymphoid and erythroid lineages
(Pronier et al., 2011). When both TET2 and TET3 are mutated in
zebraﬁsh, there are reductions in the number of hematopoietic stem
cells emerging during embryonic development (Li et al., 2015). Further-
more, TET2 mutations are implicated in the development of T-cell lym-
phomas, myeloproliferation, and myeloid malignancies, where bone
marrow precursor cells are affected (Moran-Crusio et al., 2011; Pronier
et al., 2011;Muto et al., 2014). Although the relationship of the cytosine
modiﬁcation cycle to health is limited, it is reasonable to consider that
each of the divergent leukocyte lineages may regulate the cycle
differently.
The roles for TETs and 5hmCG in leukocyte development led us to
hypothesize that various classes of peripheral leukocytes differentially reg-
ulate the establishment of 5mCG and its removal via oxidation to 5hmCG
(Fig. 1). These and other data also point to potential cause-and-effect
relationships, that these differences in sequence speciﬁc 5mCG and
5hmCG impart to each cell type more or less potential to respond to
physiological stresses and disease and in a cell type speciﬁc manner.
We looked for initial evidence that non-overlapping leukocyte classes,
isolated by our reiterative isolation protocol, might vary in the
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through changes in their DNA cytosine hydroxymethylome. Our results
identify CD4+ T cells and CD14+ monocytes as having the highest
levels of 5hmCG, but identiﬁed CD8+T cells as having the highest levels
of TET gene expression that might reﬂect turnover rates.
2. Results
2.1. Isolation of cell populations
After a number of preliminary studies, we developed three different
isolationmethods to successively and rapidly isolate a few to seven leu-
kocyte types (helper T cells, inﬂammatory T cells, monocytes, neutro-
phils, B cells, natural killer cells, and eosinophils) from single 5 ml
samples of fresh or frozen whole blood as summarized in Fig. 2. The
three methods included: (1) the isolation of CD4+ T cells, CD8+ T
cells, and CD14+ monocytes directly from whole fresh blood, (2) the
isolation of six or seven leukocyte types from whole blood using prior
red blood cell lysis, and (3) the isolation of six or seven leukocyte
types from frozen whole blood.
In determining the order of isolation that would yield the purest
samples of the seven leukocyte types, we had to consider that each of
the seven leukocyte populations are complex and often express moreFig. 2. Description of isolation protocols. Graphical outline of the three isothan one of the common plasma membrane antigens (PMAs) used to
isolate each population (Supplemental Table 1). Our results represent
an attempt to optimize isolation of deﬁned leukocyte populations free
of unwanted cell types without seriously compromising the recovery
of cell types. Three different orders of isolation were identiﬁed, where
isolation order A was used for isolation method 1 and isolation order B
was found to yield the purest cell populations for the isolated cell
types (methods 2 and 3) with the exception of one cell type, NK cells.
Isolation order C resulted in relatively pure populations of some of the
leukocyte types (e.g., CD16+ neutrophils), but not others, and is
shown to highlight the importance of the order of isolation in recover-
ing pure cell populations.
The efﬁciencies of recovery of leukocyte types from each isolation
method are estimated in Table 1.Method 1 produced the highest recov-
ery of CD4+ T cells and CD14+monocytes while Method 2 generated
the highest recovery of CD8+ T cells, CD16+ neutrophils, CD19+ B
cells, CD56+ NK cells, and Siglec8+ eosinophils. In general there was
a 30 to 80% reduction in recovery depending upon leukocyte types for
Method 3, resulting from cell lysis during the freeze-thaw process.
2.1.1. Conﬁrmation of purity of isolated cell types
Initial analysis of the purity of the seven isolated cell types was per-
formed using the four distinct nuclear morphologies (round for CD4+,lation methods (1, 2, 3) each starting with 5 ml of peripheral blood.
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cells; multilobular for CD16+ cells; bilobed for Siglec8+ cells) of pe-
ripheral blood leukocytes (Alberts et al., 1994). Purity was assessed
based on the absence of three uncharacteristic nuclear phenotypes for
six cell types with relatively unique morphologies. For CD56+ NK
cells the estimate is based on the absence of two nuclear morphologies,
multilobed and bilobed. The ﬂuorescent nuclear morphology we ob-
served for the seven isolated leukocyte types after staining with DAPI
and propidium iodide (PI) are shown in Fig. 3. After examining several
ﬁelds of cells by ﬂuorescent microscopy, each cell type isolated by the
methods and isolation orders described in Fig. 2 and Table 1, were
found to be at least 95% pure, thus meeting our criteria to be initially
considered as a highly enriched cell population pending qRT-PCR tran-
script analysis. Some of the isolated cell types were bound to numerous
dynabeads during the isolation process, making the nuclear morpholo-
gy of these cells difﬁcult to assess. Cells with obscured nuclearmorphol-
ogies are not included in our estimates of purity. Purity was further
conﬁrmed through qRT-PCR analysis of leukocyte-speciﬁc transcripts.
Most studies of isolated leukocytes use cytometry to demonstrate
that the cell types express common PMAs consistent with expectations
(i.e., CD4+ T cells are CD4+/CD3+/CD14−) (Reinius et al., 2012).
However, this approach does not quantitatively address the level of con-
tamination from other unwanted cell types, without the use of many
other marker antibodies during cytometry. The binding of multiple
large Dynabeads to cells complicates cytometry and bead removal
may damage cells. Therefore, we developed qRT-PCR assays using aFig. 3. Nuclear morphologies of isolated cell types. Isolated leukocytes, bound to Dynabeads
ﬂuorescence (left) and DIC microscopy (upper right) of each of the seven panels. The three impanel of eight leukocyte-speciﬁc marker transcripts to assess the purity
of the seven isolated cell types. The relative quantity (RQ) of expression
of each transcript in each cell type is shown in Supplemental Fig. 1A
(isolation order B, yielding the most pure leukocyte populations) and
isolation order C (shown to demonstrate the importance of isolation
order) in Supplemental Fig. 1B. Unexpectedly high levels of CD4
mRNA were observed in CD14+ monocytes and CD16+ neutrophils
(Supplemental Fig. 1A). Therefore, IFM was used to assess CD4 protein
localization in these cell types and in CD4+ T cells (Supplemental
Fig. 2). We found CD4 protein in the membrane of isolated CD4 cells,
but only in the cytoplasm of CD14+ monocytes and CD16+ neutro-
phils. The results of this analysis provided evidence that the CD4 protein
is only trafﬁcked to themembrane in the CD4+ T cells. Considering the
IFM analysis of nuclear morphology showed no round nuclei in either
the isolated monocytes or neutrophils, we can conclude that there is
no contamination of CD4+ T cells in these isolated cell populations.
As shown in Supplemental Fig. 1, NK cells captured using theCD56+
antigen express transcripts for many of the common PMAs used for cell
isolation (Supplemental Table 1), and thus represent a heterogeneous
population of cells (Kelly-Rogers et al., 2006; Poli et al., 2009). If the
order of the isolation is manipulated to isolate CD56+ NK cells last,
very few cells remain, as themajority of CD56+cells have been isolated
in the other cell populations as sub-types of these cell populations. This
is due to the co-expression of CD16 (Kelly-Rogers et al., 2006; Poli et al.,
2009; Accomando et al., 2014), CD4 (Kelly-Rogers et al., 2006; Zloza and
Al-Harthi, 2006; Gruenbacher et al., 2009), CD8 (Kelly-Rogers et al.,were stained with: DAPI (upper left blue) and PI (lower left red) and photographed by
ages were merged to yield the image in the lower right. Scale bar = 20 μm.
Table 1
Efﬁciency of recovery of each isolation method.
CD4+ T cells CD8+ T cells CD14+
monocytes
CD16+
neutrophils
CD19+ B
cells
CD56+ NK cells Siglec8+
eosinophils
Method
1 72,300 ± 6500a 34,500 ± 7400a,b 11,100 ± 1600a NR NR NR N
2 44,900 ± 4700b 39,300 ± 10,600a 3500 ± 1600b 211,000 ±
53,500a
3900 ± 800a 54,300* ±
11,100a
6400 ±
2900a
3 13,800 ± 2100c 7100 ± 2300b 4800 ± 1500a,b 43,200 ± 6700b 2800 ± 900a 14,100* ± 4500b 3600 ± 200a
Numbers of cells recovered from each isolationmethod starting with 5 ml of blood reported as Mean± SEM (N=3). Fresh bloodwith RBC lysis and frozen blood protocols were isolated
following isolation order A, except *CD56+ cells which were isolated directly from white blood cells isolated with the respective method, as they are unable to be recovered in isolation
order A. NR: Not Recovered. A one-wayANOVA followed by Tukey HSDpost hocwas performed betweenmethods 1, 2 and 3 for the three cell typeswhere cells were recovered in all three
methods. A two tailed t testwas performed betweenmethods2 and3 for the four cell typeswhere cellswere only recovered in thesemethods. Signiﬁcant differences between the different
methods for each of the seven cell types are designated by having different letters.
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(Gruenbacher et al., 2009) surface markers in some CD56+ NK cells.
For the cells assayed in Supplemental Fig. 1A, CD56+cellswere isolated
ﬁrst, hence, CD56+ cells expressing all these other markers were
included.
2.2. Utilization of isolated leukocytes for epigenetic analysis
Based on the purity of the isolated cell populations as deﬁned by nu-
clear morphology and the expression of cell type speciﬁc transcripts,
isolation order B was selected and used for the remaining experimental
analysis in this manuscript, with the exception of only the ﬁrst six cell
types were isolated following this order, while CD56+ NK cells were
isolated in parallel from an additional blood sample.
2.2.1. 5hmCG levels among leukocytes
To explore the differences in 5hmCG levels and gene-region speciﬁc
distribution of 5hmCG among leukocytes, we performed a TET assisted
bisulﬁte sequencing (TAB-Seq) genome wide analysis on DNA isolated
from each of the seven isolated cell types. The majority of the 5hmCG
modiﬁcation is found in the CG dinucleotide context, resulting from
the speciﬁcity of TET enzymes and associated DNA binding machinery
to CG dinucleotides (Lister et al., 2013; Wu and Zhang, 2014). And
thus, we ﬁrst quantiﬁed the overall level of 5hmCG in each of the cell
types (Table 2) and found that CD4+ T cells had by far the highest
level of 5hmCG at CG dinucleotides: 3.67% of CG sites assayed contained
a 5hmCG.Monocytes, neutrophils, and B cells had intermediate levels of
5hmCG: 2.69%, 2.62% and 2.38%, respectively. NK cells, eosinophils and
CD8+T cells had the lowest levelswith 2.12%, 1.99%, and 1.91%, respec-
tively. These valueswere based on the analysis of ~10 × 106 different CG
dinucleotides from each cell type.
As an independent conﬁrmation of this range of 5hmCG levels
among classes of leukocytes we performed immuno-ﬂuorescent mi-
croscopy (IFM) (Fig. 4) of 5hmC in preparations of total leukocytes co-
stained with DAPI for DNA. Preparations of leukocytes where prepared
from both fresh (method 2, Fig. 4A) and frozen (method 3, Fig. 4B)Table 2
5hmC levels are distinct among the seven classes of peripheral leukocytes.
Leukocyte type Total 5hmCG
sites
Total CG
sites
%
5hmCG
Scaled %
5hmCG
CD4+ T cell 268,707 12,379,005 2.17% 3.67%
CD14+ monocyte 155,335 10,332,947 1.50% 2.69%
CD16+ neutrophil 176,386 12,621,471 1.40% 2.62%
CD19+ B cell 144,885 10,154,660 1.43% 2.38%
CD56+ NK cell 174,264 12,397,889 1.41% 2.12%
Siglec8+ eosinophil 117,257 8,357,101 1.40% 1.99%
CD8+ T cell 158,512 13,045,103 1.22% 1.91%
Quantiﬁcation of 5hmC levels from TAB-Seq data demonstrated a modestly wide range of
5hmC levels among the peripheral leukocytes. See the Materials and methods section.blood to determine the impact of using freezing on recovery. Observa-
tion of the lowest levels of 5hmC in some cells required longer photo-
graphic exposures and a further assessment of antibody reagent
controls (Supplemental Fig. 3), however all leukocyte nuclei, as identi-
ﬁed by DAPI staining (Supplemental Fig. 3A), expressed 5hmC (Supple-
mental Fig. 3B-C) in varying degrees after this assessment, agreeing
with our TAB-Seq data. After quantiﬁcation of the 5hmC signal of at
least 100 cells of each of the four distinct nuclear morphologies
(round: T cells, B cells and NK cells; kidney: monocytes and NK cells;
multilobed: neutrophils; bilobed: eosinophils) the 5hmC signal for
each morphology was classiﬁed as minimal, low, medium or high
(Fig. 4C). A two-wayMANOVA revealed that freezing had no signiﬁcant
effect on the distribution of 5hmC signal amongnuclear types. However,
as expected, the various nuclear morphologies were a signiﬁcant deter-
minant of 5hmC levels (p=0.001). In particular, among nuclei with the
high 5hmC signal, 92.7%of the variance in 5hmC levelswas explained by
the different nuclear morphologies (p = 2.07 × 10−7) with the kidney
and round morphologies much more commonly represented than the
others. Furthermore, nuclear morphology signiﬁcantly impacted 5hmC
signal in the medium, low and minimal groups (p b 0.05, explaining
61.6%, 76.3%, and 45.5% of the variance in 5hmC signal respectively).
However, all the different nuclear morphologies were represented in
these groups. The differences identiﬁed were similar to the TAB-seq
analysis, where the CD4+ T cells with round nuclei and monocytes
with kidney shaped nuclei have the highest level of 5hmC, and lower
levels of 5hmC are found among all nuclear morphologies (i.e. all cell
types).
2.2.2. Gene-region speciﬁc 5hmCG distribution
We next assessed the gene-region speciﬁc 5hmCG proﬁle of the
seven different leukocyte types (Fig. 5). Three regions were deﬁned
for all genes, 100 kb upstream of the transcription start site (TSS), the
gene body (i.e., start to stop of transcript) and 100 kb downstream of
the transcription stop site (TTS). The gene regions examined are the
same as those used to examine gene region distribution of 5hmCG in
brain (Lister et al., 2013). 18,000 transcripts detected in leukocytes
(Palmer et al., 2006) were broken into ﬁve expression quintiles (5 of 5
representing transcripts with the highest steady state level and 1 of 5
representing transcripts with the lowest levels). All of the leukocyte
types had roughly the same pattern of gene-region 5hmCG distribution
per transcript expression quintile with the most highly expressed tran-
scripts having the highest levels of 5hmCG,with decreasing 5hmCG cor-
relating with decreasing quintile of expression (Fig. 5B). Although the
highest expression quintile for each cell type had the highest level of
5hmCG, the absolute level was different for each cell type. CD4+ T
cells had by far the highest levels of 5hmCG with a peak at 4.53% and
CD8+ T cells had the lowest levels of 5hmCG with a peak at 2.57%
(Fig. 5B). The relative differences among cell types held true across
gene location within each quintile of expression, where for the highest
expression transcript quintile, the level of 5hmCG was highest in the
CD4+T cells and lowest in the CD8+T cells following the samepattern
Fig. 4. Immuno-ﬂuorescent analysis showed a wide distribution of 5hmC levels among various classes of leukocytes. A. Total human leukocyte fraction from fresh peripheral blood
(method 2) were labeled with DAPI for DNA (ﬂuorescent green), primary antibody to 5hmC and secondary R-PE (red ﬂuorescence), and then the merged image of DAPI and 5hmC is
also presented. The same ﬁeld of cells is shown in all images. B. Total human leukocyte fraction from frozen peripheral blood (method 3) were labeled with DAPI for DNA (ﬂuorescent
green), primary antibody to 5hmC and secondary R-PE (red ﬂuorescence), and then the merged image of DAPI and 5hmC is also presented. The same ﬁeld of cells is shown in all
images. Example cells are labeled based on nuclear morphologies. K: kidney shaped (monocytes or natural killer cells), R: Round (T cells and B cells), M: Multilobed (neutrophils), B:
Bilobed (eosinophils). C. 5hmC signal was quantiﬁed, and categorized as minimal, low, medium or high for each of the nuclear morphologies in each isolation method (fresh blood:
method 2, frozen blood: method 3) and the percent of cells for each nuclear morphology was plotted for each 5hmC signal. Error bars represent standard error of the mean.
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shown in Fig. 5C and lower quintile data in Supplemental Fig. 4. The
highest 5hmCG peak for each cell type and transcript expression quin-
tiles occurred immediately after the TSS, at the beginning of the gene
body, following a valley of 5hmCG just prior to the TSS site. A dip in
the level of 5hmCG across all cell types and expression quintiles can
be seen at the end of the gene body with a second smaller peak of
5hmCG at or near the TTS (Fig. 5B).
We then examined the differences in the levels of 5hmCG for several
different leukocyte-relevant gene-ontology (GO) term categories
(Fig. 6). For GO category analysis each gene was divided into seven
smaller gene sequence locations (Fig. 6) than used in Fig. 5. This analysis
allowed us to examine both the total variance in 5hmCG levels in all cell
types assayed for each GO term, and also assess how different each cell
type is from all the others in each gene sequence location. The total leu-
kocyte data for all but two of theGO termbased gene lists (Adaptive Im-
mune Response and Leukocyte Migration) showed a dip in 5hmCG
levels around the TTS, in agreement with this analysis of larger generegions in Fig. 5. By pooling the exons into one single bin in the box
plot we no longer resolve the spike in 5hmCG at the start of the gene
body (Fig. 5). With a few exceptions, the two regions immediately
ﬂanking the TTS had some of the highest levels of 5hmCG for all leuko-
cyte types, which was obscured when we looked at the larger down-
stream region in Fig. 5.
When the differences in the weighted average of 5hmCG for all
genes in the GO term list for each cell type are examined in relation to
the 5hmCG levels observed in all leukocytes, striking differences from
the total leukocyte population emerge. As an example, for the Leukocyte
Differentiation genes, CD16+ neutrophils had much higher weighted
average of 5hmCG levels in the two regions around the TSS, far exceed-
ing 1.5 times the interquartile range (IQR) for this region of the 5hmCG
levels observed in the total leukocytes (Fig. 6). As an additional exam-
ple, CD4+ and CD8+ T cells also distinguish themselves from the
other leukocyte types with much higher and much lower levels of
5hmCG, respectively, within exons of Inﬂammatory Response genes
(Fig. 6).
Fig. 5.Gene-region-speciﬁc 5hmCG levels are distinct among the peripheral leukocyte types andvary by transcript level. A.Map deﬁning the three gene regions assayed (Lister et al., 2013).
B. 5hmCG levelswere plotted for each of the seven leukocyte types by quintile of transcript expression level. The peak percentage of 5hmCG relative to total CG content for each cell type is
estimated at the top of each graph. C. The 5hmCG levels for the quintile of the highest quintile of transcript for each cell type was plotted together. The dots plotted with each line on the
graph represent the degree of change from the previous regions level of 5hmCG to the current level. The ﬁgure legend to the right of panel C shows the varying levels of signiﬁcance of this
change as determined by NLP. The relative position of each cell type is the same when these data are plotted for the other 4 quintiles of transcript expression (Supplemental Fig. 4).
Fig. 6. Gene-sequence-speciﬁc distribution of 5hmCG levels in the peripheral leukocytes for relevant GO term gene lists. The fraction of 5hmCG relative to all CG dinucleotides for seven
gene sequence locations in all leukocytes (100 bp upstream of the TSS (UTSS), 100 bp downstream TSS (DTSS), 100 bp upstream of all exons (UEXON), within exons (EXON), 100 bp
downstream of exons (DEXON), 100 bp upstream TTS (UTTS), and 100 bp downstream TTS (DTTS)) were plotted for different GO terms related to leukocyte function as box plots with
the bar representing the median, and the box extending from the 25th to 75th percentiles. The whiskers represent ±1.5 times the interquartile range. Within each box plot the
weighted average of 5hmCG for each leukocyte type was plotted as a colored dot, while the box is the weighted average for all 7 cell types. Similarly plotted data for several other
genes grouped by GO terms are presented in Supplemental Fig. 5.
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terms, but there are also differences in the level of 5hmCG for total leu-
kocytes across GO terms. Most of the GO terms related to leukocyte
function had variable levels of 5hmCG across the different gene regions
assayed,with the exception of the Adaptive Immune Response gene list,
where the level of 5hmCG is relatively constant across gene regions
with the exception of the 100 nt downstream of the TTS, where levels
of 5hmCG are three times higher (Fig. 6). The peak level of 5hmCG
across these smaller gene regions among the gene lists are variable
with some reachingmore than 7.5% (Cytokine Production and Adaptive
Immune Response), while others only reach ~4% (Immune System Pro-
cess, Leukocyte Differentiation, and Leukocyte Activation). Additional
GO terms related to general cell function were also examined and are
presented in Supplemental Fig. 5.
It seemed possible that any one of three factors (1) the genomic bin
(the gene-region speciﬁc location), (2) the cell type, and/or (3) the GOFig. 7. Expression of transcripts encoding enzymes involved in the establishment and removal
performed on cDNA prepared from seven leukocyte types. Values are expressed as a scaled Rel
signiﬁcant differences of at least p b 0.05. A. Analysis of transcripts for DNMTs (Fig. 1). The RQ va
for DNMT1, DNMT3A, and DNMT3B, respectively. B. Analysis of transcripts for TETs (Fig. 1). The R
value for TET1, TET2, and TET3, respectively. C. Analysis of transcripts for GADD45s (Fig. 1). The R
value for GADD45A, GADD45B, and GADD45G, respectively.term-based gene set might account disproportionately for the variance
in our data, weighting its biological relevance. Therefore, we examined
the variance in 5hmCG levels separately for these three factors (Supple-
mental Fig. 6). For all leukocyte types, the gene-region speciﬁc location
and the cell type explained approximately 31%of the variance in 5hmCG
levels, ~16% and ~15%, respectively. The different gene ontology gene
lists explained less (~7%) of the variance in 5hmCG levels. Hence,
there are many factors controlling 5hmCG levels and its gene-region
distribution in leukocytes.
2.2.3. Expression of factors involved in regulation of DNA 5hmCG levels in
peripheral leukocyte types
We used qRT-PCR to determine the relative quantity (RQ) of each
transcript for nine factors involved in the DNA cytosine methylation
cycle (DNMT1, 3A and 3B, TET1, 2, and 3, GADD45A, B, and G) as
shown in Fig. 7. DNMT1 was 8- to 16-fold more highly expressed inof modiﬁed DNA cytosine. A–C. qRT-PCR analysis of the relative transcript expression was
ative Quantity (RQ) of transcript in each cell type using the dCT method. Letters designate
lue for each cell type is presented as a scaled value of 104, 105, and 106 times their RQ value
Q value for each cell type is presented as a scaled value of 106, 105, and 105 times their RQ
Q value for each cell type is presented as a scaled value of 105, 105, and 106 times their RQ
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8- and 4-fold more highly expressed in the CD4+ T cells (p b 0.0005)
and CD8+ T cells (p b 0.05), respectively, than in the 5 other cells
types (Fig. 7A). TET1 was 50-fold more highly expressed in the two T
cell types than other leukocytes (p b 0.0005). TET2 was 10- to 50-fold
higher in the CD8+ T cells and eosinophils than in 4 other cell types
(p b 0.005). TET3wasmost highly expressed in eosinophils, monocytes,
and CD4+ T cells than the other leukocyte types (p b 0.05) (Fig. 7B).
GADD45A was 50-fold higher in CD8+ T cells than in all other cell
types (p b 0.0005). GADD45B was 8- to 16-fold higher in both T cell
populations relative to all other cell types (p b 0.0005), except for eosin-
ophils, where it was modestly expressed. GADD45Gwas 15-fold higher
in the CD4+ T cells than in the other cell types (p b 0.0005), again with
exception of modest expression in eosinophils (Fig. 7C). In summary,
there are dramatically different expression proﬁles for many of the en-
zymes central to the turnover of modiﬁed cytosine residues (Fig. 1)
among classes of leukocytes.3. Discussion
3.1. Isolating sub-populations of leukocytes
Before testing our hypothesis that the various classes of peripheral
leukocytes differentially regulate the establishment of 5mCG and its
removal via oxidation to 5hmCG, we ﬁrst optimized methods to quickly
and reiteratively isolate a few to seven of the peripheral blood leukocyte
types from small samples of fresh or frozen stored blood. Our approach
represents an extension of the partially reiterative methods of Lyons
et al. (2007), who started with two aliquots of PBMCs and then succes-
sively isolated CD14+monocytes and then CD4+ T cells from one ali-
quot and the CD19+ B cells followed by CD8+ T cells from the other.
Most other reports of blood cell methylome analysis start with large
amounts of blood (e.g., 100 to 450 ml) and isolate single cell types
from separate aliquots (Reinius et al., 2012; Zilbauer et al., 2013). Such
large blood samples are not easily adapted to the analysis of large pa-
tient populations particularly if multiple cell types are to be isolated.
Furthermore, typical protocols for leukocyte isolation rely on Ficoll den-
sity centrifugation to ﬁrst purify the leukocyte population from the red
blood cells prior to individual cell type isolation, which takes time and
effort and results in a signiﬁcant loss of cells. This is of concernwith epi-
genetic analysis, as the half-life of promoter region speciﬁc DNA meth-
ylation for many genes is measured in fractions of an hour (Meagher,
2014). Hence, any additional time of manipulation may result in the
loss of the original methylation proﬁle. Our protocol(s) allows for
rapid isolation of several relatively pure leukocyte populations with
minimal time and labor compared to the current methods.
If multiple cell types are to be isolated from one blood sample, six to
ten color ﬂow cytometry and sorting has the potential to identify and
eliminate contamination of subpopulations expressing multiple
markers (Roederer et al., 1997; Granja et al., 2015; Melzer et al., 2015)
and providemore information about the cell populations thanmagnetic
bead isolation. However, multichannel sorting is more technically chal-
lenging andmore costly. In addition, during cytometry “contamination”
of one cell type with another depends not only upon co-expressed
markers, but also on the choice of ﬂuorophores and their overlapping
emission spectra. While the reiterative isolation of cell types employed
herein is less complex, less expensive, and more rapid, it may not
achieve the level of purity possible using multichannel FACS.
The current common criterion for assessing purity of isolated leuko-
cyte types relies on ﬂuorescently labeling isolated cells with a panel of
antibodies and subsequent analysis by ﬂow cytometry (Reinius et al.,
2012; Accomando et al., 2014). However, we were confronted with
the problem that the large 2.8 or 4.5 micron diameter Dynabeads used
to capture cells would have to be dissociated from cells before cytomet-
ric analyses. Therefore, to conﬁrm purity by a technique independent ofcytometry we employed qRT-PCR analysis of transcripts encoding eight
deﬁning PMA marker proteins.
3.2. Evidence for extreme variability in the regulation of 5mCG and 5hmCG
levels among classes of leukocytes
We examined the levels of 5hmCG and related proteins regulating
synthesis and decay of 5mCG levels among leukocytes.Wewere explor-
ing the idea that the leukocyte types with higher levels of 5hmCG and
enzymes leading to 5hmCG synthesis and removalwould bemore read-
ily poised to respond to different environmental stimuli via changes in
DNA demethylation and rapid changes in transcription. We hoped
these data would begin to deﬁne those classes of blood-borne leuko-
cytes with the greatest potential to respond rapidly to changes in the
cell, tissue, and blood environment. However, we have not yet directly
tested the response of the methylome of different cell types to environ-
mental stress.
Our goal was a broad survey of 5hmCG across all of the peripheral
leukocyte types. When we examined 5hmC by IFM in a total leukocyte
preparation, we found that all cells examined expressed 5hmC at
some level (Supplemental Fig. 3), and that the level of 5hmC varied dra-
matically among leukocyte types (Fig. 4). However, there was no differ-
ence in the 5hmC levels as determined by IFM for total leukocytes
isolated with either method 2 (fresh blood) or 3 (frozen blood)
(Fig. 4) and thus we only examined one isolation method in our further
analysis. The analysis of 5hmC levels was expanded and quantiﬁed
using TAB-Seq and showed a wide variation among leukocytes
(Table 2). Themodestly high levels of 5hmCG in all peripheral leukocyte
types suggests that all peripheral leukocytes are able to alter their 5mCG
levels via hydroxymethylation, presumably in response to different
physiological signals.
However, it should bementioned that a direct relationship between
the loss of 5mCG and the gain of 5hmCG should not be expected, as
there are many regulated steps in the cycle, and the half-lives of all
the intermediates may vary in a site speciﬁc manner. In other words,
these two modiﬁcations may change independently in different gene
sequences and in different cell types in a tissue (Ruzov et al., 2011;
Salvaing et al., 2012; Hahn et al., 2013). With a few exceptions, we did
not observe a clear relationship between the relative levels of 5hmCG
among the 7 leukocyte types and the levels of 5mCG reported previous-
ly (Reinius et al., 2012). This comparison supports the view that
the cytosine modiﬁcation cycle is quite distinctly regulated in each cell
type.
Further, we did not ﬁnd a simple correlation between the expression
of transcripts encoding enzymes involved in the turnover of modiﬁed
cytosine residues (e.g., TETs, GADD45s, Fig. 1) and the levels of
5hmCG among the seven leukocyte types, although some speculation
about these relationships seems warranted. CD4+ T cells have by far
the highest levels of 5hmCG (Table 2, Fig. 5) and they have the highest
levels of 5mCG of any leukocyte type assayed (Reinius et al., 2012). It
is tempting to speculate then, that they are the most highly potentiated
to respond to stress by 5hmCG mediated changes in 5mCG levels
followed by changes in gene expression. Yet, CD4+ T cells did not dis-
tinguish themselves with high levels of expression of those factors con-
trolling the synthesis of 5hmCG. They did highly express TET1, DNMT1,
DNMT3A, andGADD45G. These data suggest there is another level of reg-
ulation controlling the balance among the factors in the turnover cycle
of cytosine modiﬁcation (Fig. 1).
Overall, CD8+ T cells expressed relatively high steady state levels of
transcripts encoding most of the factors involved in this cycle (DNMT1,
DNMT3B, TET1, TET2, GADD45A, and GADD45B). Despite this, CD8+ T
cells had the lowest levels of 5hmCG for all quintiles of transcript ex-
pression. CD8+ T cells have moderately high levels of 5mCG relative
to other PBMCs (Reinius et al., 2012). Hence, the balance among these
modifying activities (examine Figs. 1 and 7) for CD8+ T cells must be
weighted toward accumulation of 5mCG and rapid removal of 5hmCG.
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responsive in changing 5mCG levels, despite having low levels of
5hmCG. It has been shown there are dynamic changes in DNA cytosine
methylation in CD8+ T cells in response to acute infection (Scharer
et al., 2013), supporting the view that the cycle turns over rapidly in
these cells. This emphasizes the importance of both DNA demethylation
and methylation in the ability of CD8+ T cells to respond to changes in
their environment (Scharer et al., 2013).
CD14+ monocytes have relatively low levels of all the factors
assayed with the exception of TET3, and yet they have the second
highest levels of 5hmCG. By contrast they have 2 to 3 times lower levels
of 5mCG relative to other PBMCs (Reinius et al., 2012). Hence, these
modifying activities must be weighted toward removal of 5mCG and
accumulation of 5hmCG. Granulocytes, CD16+ neutrophils and
Siglec8+ eosinophils have the lowest levels of 5mCG (Reinius et al.,
2012), but have moderate and low levels of 5hmCG, respectively
(Table 2, Fig. 5).
Interestingly, the two cell types with the highest levels of 5hmCG,
CD4+ T cells and CD14+ monocytes, both expressed high levels of
transcripts involved in the removal of 5hmCG (TETs and GADDs),
which may seem counterintuitive. Perhaps the TET activity in these
two cell types efﬁciently carry out the ﬁrst oxidation step from 5mC to
5hmC, but are less efﬁcient at further oxidation. Those sites that are ox-
idized further to 5fC and 5caC may be repaired by the base excision re-
pair (BER) pathway back to C and then further modiﬁed to 5mC and
then back to 5hmC. This proposed mechanism emphasizes the impor-
tance of the modiﬁcation cycle for DNA cytosine (Fig. 1). Both of these
cell types also express high to modest levels of the DNMTs, further
strengthening this explanation.
When we examined the 5hmCG distribution across gene regions
among the quintiles of gene expression (Fig. 5) for the seven leukocyte
types, we observed a strong depletion of 5hmCG at the TSS and an en-
richment over the gene body. These data agree with previous work
assessing 5hmCG distribution in T cells (Tsagaratou et al., 2014;
Ichiyama et al., 2015), as well as other non-leukocyte cell types and tis-
sues (Song et al., 2011; Mellen et al., 2012; Yu et al., 2012b; Chapman
et al., 2015; Taylor et al., 2016). In genes with the highest levels of ex-
pression (Fig. 5), we observed an enrichment of 5hmCG in the gene
body, suggesting that higher gene body 5hmCG correlateswith the acti-
vation of these genes. Gene body enrichment of 5hmCG and its associa-
tion with highly expressed cell type speciﬁc genes have been observed
in studies of the brain, neurons, colonocytes, and chondrocytes
(Mellen et al., 2012; Hahn et al., 2013; Chapman et al., 2015; Taylor
et al., 2016).
Higher and lower levels of 5hmCG in both the total leukocytes and
the individual cell types were observed in our analysis of smaller gene
regions (Fig. 6) than what we had observed in larger gene regions
(Fig. 5), because the extreme levels are averagedout by adjacent regions
when larger gene regions are examined. The highest 5hmCG level in the
different gene regions and GO terms were not always in the CD4+ T
cells as we have observed for large gene regions Fig. 5. For example, in
the Cytokine Production GO gene list in the region upstream of the
TTS, CD14+ monocytes have high 5hmCG levels (~8%) and in the re-
gion downstream of the TTS, Siglec8+ eosinophils and CD19+ B cells
have levels reaching ~8.5% (Fig. 6). The Siglec8+ eosinophils have the
second lowest global 5hmCG level as well as the second lowest peak
5hmCG levelwhen examined by transcript expression quintile and larg-
er gene regions. This may suggest that although globally there are gen-
erally low levels of 5hmCG in the eosinophils, there are gene-region and
gene-type differences in 5hmCG in this cell type (and others) that may
be important to gene regulation of speciﬁc genes and would be missed
by both global analysis and transcript expression quintile analysis of
larger gene regions.
Cell type speciﬁc changes in 5hmCG in relation to different GO clas-
ses of genes and gene region may be relevant to the role of 5hmCG in
potentiating gene expression. For example, during chondrogenesisthose genes for which increases in 5hmCG correlate with increases in
gene expression there was a enrichment of 5hmCG both prior to the
TSS and in the gene body and a sharp drop in between (Taylor et al.,
2016). This distribution of 5hmCG was not observed in the genes with
either no change in expression or a decrease in expression associated
with large changes in 5hmCG (Taylor et al., 2016). Our data (Fig. 6)
also shows this relationship. For example, when neutrophils were ex-
amined for the leukocyte activation GO gene list we saw enrichment
of 5hmCG in the region prior to the TSS and in the gene bodywith a val-
ley in between. By contrast, when the adaptive immune response GO
gene list is applied to neutrophils, an innate immune cell type, this en-
richment pattern of 5hmCG is not observed. These data support the
idea that gene region speciﬁc enrichment of 5hmCG is cell type speciﬁc
in leukocytes, potentiating the expression of cell type speciﬁc genes for
regulated gene expression.3.3. The role of hydroxymethylcytosine in potentiating gene regulation
A current view is that high levels of gene region speciﬁc 5hmCG po-
tentiate genes for “on demand gene regulation”(Irier et al., 2014). Fur-
ther, there is direct evidence that this cytosine modiﬁcation is
essential for normal regulation of gene expression. For example, during
erythropoiesis in zebra ﬁsh, there is both increased expression and de-
methylation of scl, gata-1, and cmyb. However, if TET2 is knocked
down there is increased methylation and decreased expression of
these genes that results in anemia (Ge et al., 2014) suggesting a direct
role for 5mCG oxidation in essential gene regulation. In embryonic
stem cells, when TET1 and TET2 are knocked down, there is an increase
in methylation of the pluripotency related genes with a corresponding
decrease in expression, altering their differentiation potential (Ficz
et al., 2011).
5hmCG rich regions are associatedwith a potentiated, open chroma-
tin state allowing access to various transcription and chromatin remod-
eling factors. For example, in embryonic stem cells enhancer regions
enriched for 5hmCG are also enriched for nucleosomal histone modiﬁ-
cations H3K4Me1 and H3K27Ac, which are associated with active tran-
scription (Szulwach et al., 2011). In addition, in CD4+/CD8+ double
positive thymocytes, 5hmCG is enriched in active thymus-speciﬁc en-
hancers, which have high levels of H3K4Me1 and H3K27Ac
(Tsagaratou et al., 2014). There is also a negative correlation between
5hmC and the repressive histone modiﬁcation H3K27me3 (Tsagaratou
et al., 2014). It has been suggested that the combination of these chro-
matin structures indicates genes that are poised for transcriptional acti-
vation or silencing in response to environmental cues (Lister et al.,
2013; Tsagaratou and Rao, 2013; Tsagaratou et al., 2014).
Considering that oxidation of 5mC to 5hmCmust impact 5mC levels
it is worth considering the contribution of 5mC binding protein to the
concept of 5hmC function. 5mCG dinucleotides attract a wide variety
of chromatin remodeling machinery such as methyl-CG binding pro-
teins MBD4 and MeCP2 (Du et al., 2015). MBD4 recognizes 5hmCG
and has a glycosylase domain (Otani et al., 2013) (see Fig. 1, TDG) and
therefore, may contribute to the cyclic modiﬁcation and removal of cy-
tosine (Fig. 1) in various classes of leukocytes. The binding and activity
of MeCP2 appears enhanced at promoter 5hmCG sites in the brain
(Zhubi et al., 2014) and its activity is considered particularly important,
because in the brain MeCP2 activity responds to external stimuli
(e.g., cocaine, ethanol) (Pol Bodetto et al., 2013; Liyanage et al., 2015).
MeCP2 binding in the brain tomodiﬁed C residues canwork to enhance
transcription if bound to 5hmCG, or repress transcription if bound to
5mCG (Mellen et al., 2012). Appropriate levels of MeCP2 activity are es-
sential for the differentiation of naive CD4+ T cells into a variety of T
cell types (Jiang et al. 2014; Yang et al. 2012). Thus it appears that the
balance between 5mCG and 5hmCG is allowing the DNA sequence to
be poised for activation and expression or repression via a combination
of interactions with methyl-binding proteins.
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the role of 5hmCG that may still be valid, stating that “5hmC contributes
to the 'poised' chromatin signature found at developmentally-regulated
genes”. On the other hand, Nestor et al. (Nestor et al., 2012) presented
solid evidence that “tissue type” was “a major modiﬁer of the 5-
hydroxymethylcytosine content” of genes. It is reasonable for us to inter-
pret tissue type as leukocyte type and expect gene speciﬁc differences
among cell types when a genome-wide analysis is performed. Our
data herein and that from mouse brain (Lister et al., 2013) agree with
both views, suggesting that gene expression levels and cell type are
both signiﬁcant determinants of overall 5hmCG levels. In short, gene
region-speciﬁc 5hmCG level differences between active and inactive
chromatin regions are preserved within a background of higher or
lower total 5hmCG, which is determined by the cell type. Perhaps it is
important to recall that the sevenmajor classes of leukocytes examined
are indeed quite divergent.
3.4. Conclusions
In summary, we optimized protocols for the reiterative isolation of
the major leukocyte types from single small whole blood samples that
are rapid and efﬁcient. The isolated populations of the various leukocyte
types appear sufﬁciently pure for epigenome and transcriptome studies.
Thiswas conﬁrmedwith the analysis of both nuclearmorphology and of
leukocyte cell-type speciﬁc transcripts.
We showed that these seven isolated leukocyte types, (1) differen-
tially express factors involved in the cycle of DNA cytosine methylation
and demethylation, (2) have rank order differences in 5hmCG levels
and gene region dispersal, and (3) collectively our data suggest that
the CD4+ and CD8+ T cells and CD14+monocytes may be potentiat-
ed to turnover their 5mCG more rapidly via oxidation to 5hmCG than
other leukocytes. However, there is not a simple relationship between
TET expression levels and 5hmCG levels as suggested by our hypothesis,
implying that amuch better understanding of every step in the cytosine
modiﬁcation cycle is needed. Recall that TETs catalyze the further oxida-
tion of 5hmCG to 5fCG and 5caCG (Fig. 1). Taken together our data sug-
gest that each leukocyte type uniquely regulates their cycle of DNA
cytosine modiﬁcation, which imparts to each cell type a distinct ability
to regulate gene expression in response to different physiological cues.
Deﬁnitive identiﬁcation of the optimal surrogate leukocyte cell types
in peripheral blood to report themethylome's response to health status
awaits further experimental analysis. It still needs to be established that
5hmCG levels and components of the turnover cycle for cytosine mod-
iﬁcation enable some cell types to respondmore rapidly or more deﬁn-
itively than others to distinct physiological stresses and diseases.
4. Materials and methods
4.1. Methods of reiteratively isolating leukocytes
Building on previous efforts to reiteratively isolate some classes of
peripheral blood leukocytes (Lyons et al., 2007) we developed simpli-
ﬁed protocols that could be executed in 5 hours on six or seven leuko-
cyte classes (Figs. 2-3, Supplemental Figs. 1-2, Table 1). Venous blood
samples were collected in EDTA tubes in the morning between 8 and
9 AM from a nonfasted healthy 65-year-old male volunteer free of car-
diovascular and other diseases with a BMI of 29. These studies were ap-
proved by the Institutional Review Board at the University of Georgia.
Analyzing the methylome of seven cell types from one individual in
this initial study eliminated genetic variation so as to strengthen the in-
terpretation of complex data, as was done with the early studies of bi-
sulﬁte conversion for analyzing 5mCG residues, TET-assisted bisulﬁte
sequencing for analyzing 5hmCG residues, and six color sorting for the
analysis of multiple leukocyte types (Frommer et al., 1992; Roederer
et al., 1997; Yu et al., 2012a). However, we have not yet addressed the
natural variability in the leukocyte populations or in chromatinstructures that may exist among healthy individuals differing in age
and/or sex.
Leukocytes were isolated following the methods described in detail
below and are depicted in Fig. 2. For eachmethod the cells were isolated
in the following order: (A) CD4+ T cells, CD8+ T cells, and CD14+
monocytes, respectively, (B) CD16+neutrophils, Siglec8+ eosinophils,
CD4+ T cells, CD8+ T cells, CD19+ B cells, CD14+ monocytes, and
CD56+ NK cells, respectively, and (C) CD14+ monocytes, CD4+ T
cells, CD16+ neutrophils, CD56+ NK cells, CD8+ T cells, CD19+ B
cell, and Siglec8+ eosinophils, respectively. The majority of leukocyte
data presented in the text utilize Method 2 in which six of the cell
types were reiteratively isolated from one 5 ml fresh blood sample in
isolation order B, while the seventh type, CD56+NK cells were isolated
in parallel from a second 5ml blood sample, becauseNK cells are a high-
ly mixed cell type in terms of the afﬁnity markers being utilized, their
recovery is poor when isolated at the end of isolation order B.
4.1.1. Dynabead preparation
Anti-CD4, anti-CD8, and anti-CD14 antibodies bound to 4.5 μmpara-
magnetic Dynabeads were obtained from Life Technologies (Grand Is-
land, NY, USA Cat# 11145D, 11147D, 11149D). 25 μl of suspended
anti-CD4+ and anti-CD8+ Dynabeads and 20 μl of suspended anti-
CD14+Dynabeadswere used per 5ml of blood. TheDynabeadswepre-
pared per manufacturer’s instructions and stored in 50 μl of PBSBE
(phosphate buffered saline, 1% BSA, 2 mM EDTA, pH 7.4) on ice until
needed. Protein G Dynabeads (2.8 μm, Life Technologies, Grand Island,
NY, USA Cat# 10009D) were coupled to anti-CD16 (Santa Cruz Biotech
Dallas, TX, USA Cat# sc-19620), anti-CD19 (Bio legend San Diego, CA,
USA Cat# 302202), anti-CD56 (Bio Legend, San Diego, CA, USA Cat#
31824), or anti-Siglec8 (Bio Legend, San Diego, CA, USA Cat# 347102)
antibodies for the isolation of 4 other leukocyte classes. Protein G
Dynabeads were ﬁrst washed with 1 ml of PBSBE, resuspended in
200 μl of PBSBE where the antibody was then added (40 μl Dynabeads
and 4 μl anti-CD16 or 10 μl Dynabeads and 0.5 μl of anti-CD19, anti-
CD56, and anti-Siglec8). Beads and antibodies were incubated at room
temperature with rotation for 15 min, washed twice with 1 ml PBSBE,
resuspended in 50 μl of PBSBE and stored on ice for no more than 4 h
until use. Washing was implemented with the use of strong neodymi-
um magnets that pulled the Dynabead-bound cells to the side of a
1.5 ml microfuge tube (MagnaRack, Invitrogen, Grand Island, NY, USA
Cat # CS15000) in a minute.
4.1.2. Method 1: isolation of leukocytes from fresh whole blood without red
blood cell lysis (Fig. 2)
Fiveml of venous blood samples were collected in EDTA tubes in the
morning between 8 and 9 AM in a nonfasted male subject (kept on ice
immediately after collection until leukocyte isolation) and were diluted
1:2 with PBSBE and centrifuged at 300 ×g for 30 min at 4 °C. Superna-
tant was discarded, and the cell pellet was resuspended in 1 ml of
PBSBE. Cells were centrifuged at 400 ×g for 2 min, supernatant was
discarded, and cells resuspended in 1ml of PBSTBE (phosphate buffered
saline, 2% Tween 20, 1% BSA, 2mMEDTA, pH 7.4). Three leukocyte types
(CD4+, CD8+, and CD14+) were then successively isolated following
the general isolation protocol (see below).
4.1.3. Method 2: isolation from fresh whole blood with controlled red blood
cell lysis (Fig. 2)
Fiveml of venous blood samples were collected in EDTA tubes in the
morning between 8 and 9 AM in a nonfasted male subject (kept on ice
immediately after collection until leukocyte isolation) and were diluted
1:10 with freshly prepared 1× cold red blood cell lysis solution form a
10× stock (10× red blood cell lysis solution: 1.5 M NH4Cl 100 mM
NaHCO3, 10 mM EDTA, pH 7.4) (Bossuyt et al., 1997) and placed on
ice for 20 min. Samples were then centrifuged at 300 ×g for 20 min at
4 °C. Supernatant was discarded, and cells were resuspended in 10 ml
of PBSBE and centrifuged at 300 ×g for 10 min at 4 °C. Supernatant
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to seven leukocyte types were then successively isolated following the
general isolation protocol.
4.1.4. Method 3: isolation from frozen whole blood (Fig. 2)
Venus blood samples were collected in EDTA tubes in the morning
between 8 and 9 AM in nonfasted a male subject and frozen at
−80 °C. Five millilitres of frozen blood (at −80 °C) was thawed on
ice. Approximately 90% of red blood cells lyse during the freeze-thaw
process, but most white cells do not (Fiebig et al., 1997). Thawed
blood was diluted 1:2 with PBSBE and centrifuged at 300 ×g for
30 min at 4 °C. The supernatant was discarded, and cells were resus-
pended in 1ml of PBSBE. Cells were centrifuged at 400 ×g for 2min, su-
pernatant was discarded, and cells were resuspended in 1ml of PBSTBE.
Again, six to seven leukocyte types were then successively isolated fol-
lowing the general isolation protocol.
4.1.5. General isolation protocol
Dynabeads prepared for the ﬁrst cell type to be isolated were added
to the cells. Cells were incubated with Dynabeads with rotation at 4 °C
for 30 min for CD4+ T cells, CD8+ T cells, CD14+ monocytes,
CD19+ B cells, CD56+ natural killer (NK) cells, and Siglec8+ eosino-
phils or 1 h for CD16+ neutrophils. Samples were then placed on a
magnetic rack (Invitrogen, Grand Island, NY, USA Cat # CS15000) for
2 min, and the supernatant was carefully removed, placed in a fresh
microcentrifuge tube for the next leukocyte type to be isolated, and
stored on ice until processing. The cells bound to paramagnetic beads
were resuspended in 1 ml of PBSBE and washed three times with
PBSBE using the magnetic rack. Cells were ﬁnally resuspended in
200 μl of PBS (phosphate buffered saline, pH 7.4) and stored according
to future use (e.g., the cell pellet was frozen with liquid nitrogen and
stored at −80 °C for RNA, frozen at −80 °C for DNA extraction or
ﬁxed with 3.7% formaldehyde for Immuno-Fluorescent Microscopy
(IFM)). The Dynabeads prepared for the next cell type to be isolated
were added to the microcentrifuge tube containing the uncaptured
cells, and the next cell type was isolated following the same protocol.
This processwas repeateduntil all desired leukocyte types had been iso-
lated. When we tried to use this capture method with the white blood
cells suspended in 10 ml the recovery was not quantitative, even with
longer incubation times, using twice as much antibody and beads, and
larger neodymium magnets.
4.1.6. Determination of cell recovery for each isolation method
Ten μl of the formalin ﬁxed cells of each cell type were incubated for
20min in the dark at 4 °Cwith 0.25 μl of Propidium Iodine (PI, 1mg/ml).
Stained cells were examined on a hemocytometer under combined
ﬂuorescence and DIC, and cells were counted following standard proto-
cols. Florescence microscopy was performed on a Leica TR600
epiﬂuorescence microscope using Hamamatsu SimplePCI Image Analy-
sis software or on a confocal microscope (Zeiss SM710) using ZEN 2011
software. A one-wayANOVA followed by Tukey's HSDpost hocwas per-
formed using SPSS software (IBM) to determine differences in cell re-
covery between the three methods of isolation for the three cell types
where cells were recovered for all three methods. Signiﬁcance was set
at p b 0.05. A two tailed t test was performed on the cell recoveries be-
tween methods 2 and 3 to determine any signiﬁcant differences in cell
recovery between the two methods for the four cell types in which
cells were only recovered in these methods. Signiﬁcance was set at
p b 0.05. Data are presented in Table 1.
4.1.7. Assessment of nuclear morphology by ﬂuorescent microscopy
Initial cell puritywas assessed bymicroscope analysis of the four dis-
tinct nuclear morphologies characteristic of the various leukocyte types
(Alberts et al., 1994). Samples for analysis were prepared the same as
used to determine cell recovery. Analysis of at least 100 cells showed
that all cell preparations assayed were greater than 95% pure, basedon the presence of the correct nuclear morphology and the absence of
the alternate morphologies. Red blood cells were seldom observed.
Data are presented in Fig. 3.
To conﬁrm the purity of CD16+ neutrophils and CD14+ mono-
cytes, we ﬂuorescently labeled the total leukocyte fraction with DAPI
and anti-CD4-Texas RPE (Invitrogen, Grand Island, NY, USA Cat#
MHCD0417). First the cells were blocked for 45 min with PBSBE,
washed 3×, and stained with DAPI and the ﬂuorescent antibody for
1 h with rotation in the dark. Cells were then washed 3× with PBSBE
and a 20 μl aliquot was set aside for immediate microscope analysis
while the remaining cells were split into three equal aliquots. CD4+,
CD14+, and CD16+ were then isolated from one of the three samples
of labeled leukocytes and then immediately analyzed by ﬂuorescentmi-
croscopy. Cells positive for the CD4 antibodywere classiﬁed by their nu-
clear morphology and all cells were counted into their respective
classiﬁcations. The percentage of each cell type was then calculated. A
one-way ANOVA followed by Tukey HSD post hoc test was used to de-
termine signiﬁcant differences between each of cell populations for
each cell type using SPSS software (IBM).
4.1.8. qRT-PCR analysis of transcript levels
To further conﬁrm the purity of the cell types, we performed qRT-
PCR assays for eight transcripts speciﬁc to the seven isolated cell types
(CD3, CD4, CD8, CD14, CD16, CD19, CD56 and Siglec8. Leukocytes
bound to Dynabeads (Method 3, Order B) were washed in PBS and fro-
zen in liquid nitrogen and stored at−80 °C. RNA was extracted using
RNeasy Mini Kit (Qiagen, Frederick, MD, USA Cat# 74104) following
manufacture instructions. RNA concentrations were quantiﬁed using
Qubit RNA assay kit (Life technologies, Grand Island, NY, USA Cat#
Q32855) and 400 ng of RNA was used for cDNA synthesis using qScript
cDNA synthesis supermix (Quanta Biosciences, Gaithersburg, MD, USA
Cat# 95148-100). Relative quantities (RQ) of cell type speciﬁc tran-
scripts were normalized to an endogenous control, Beta Actin (ACTB)
(Vandesompele et al., 2002) using the dCT method (Livak and
Schmittgen, 2001). ACTB was used when we were examining the ex-
pression proﬁle of the transcripts of cell type markers within a single
cell type, and not making comparisons among cell types. ACTB mRNA
abundance, and hence, its CT values were closer to those of the target
transcripts being examined, however expression was variable across
cell types (Supplemental Fig. 7). Oligonucleotide primer sequences
(Supplemental Table 2) were synthesized by Integrated DNA Technolo-
gies (Coralville, IA, USA). Two to six primer sets were tested for each of
the target genes, ensuring the speciﬁc gene target was being ampliﬁed,
and those having a single sharp dissociation peak and the lowest CT
values were selected for subsequent use. A 25 μl reaction using SYBR
green master mix (Life Technologies, Grand Island, NY, USA Cat#
43677659) and 4 ng of cDNA was used for analysis of the eight gene
panel in all seven isolated leukocyte types. To determine statistical rel-
evance of differences in transcript levels, a one-way ANOVA was used
to examine the effects of cell type on expression with Tukey’s HSD test
as a post hoc using Statistica software 7.1 (StatSoft; Tulsa, OK, USA).
4.2. TAB-Seq library preparation and sequencing
DNA (0.5 to 1 μg) was prepared from all seven isolated cell types (1-
to 2- x 105 cells) while still attached to Dynabeads using DNeasy kit
(Qiagen, Frederick, MD, USA #69506) according to the manufacturer's
recommendations. DNA was quantiﬁed using a Qubit 2.0 Instrument
and dsDNA HS Reagent (Life Technologies, Grand Island, NY, USA
#Q32866 and #Q32851 respectively). TET-enzyme assisted bisulﬁte se-
quencing (TAB-Seq) was performed as described previously (Yu et al.,
2012a). Brieﬂy, 0.5 ng of M. SssI methylated Lambda DNA and 0.25 ng
of hydroxymethylated pUC19 DNA was added per 1 μg of DNA prior to
treatment as C/5mCG and 5hmCG control respectively and then se-
quencing libraries were prepared following the MethylC-seq protocol
(Urich et al., 2015) (Supplemental Table 3). Deep sequencing was
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of Georgia Genomics Facility. The limitation of our TAB-Seq analysis is
that there is only moderate to low coverage of the genome and thus it
is only statistically valid to look at groupings of genes and not individual
genes. Our coverage for the different cell types ranged from 34% to 55%
of the human genome (Supplemental Table 3), which is considerably
above accepted levels for a meta-analysis (Popp et al., 2010) and
hence the analysis of gene groupswithmore than 100 genes gave statis-
tically sound results.
4.2.1. TAB-Seq data analysis
The raw sequence readswere trimmed for adapters, preprocessed to
remove low quality reads and aligned as previously described in (Yu
et al., 2012b) to the Homo sapiens GRCh38 reference genome. Fully
unmethylated lambda DNAwas treated byM. SssI tomethylate all cyto-
sines in the CG context to 5mCG. These 5mCG sites in CG contexts were
used to calculate the 5mCG non-conversion rate upon TET and bisulﬁte
treatment. Non-CG sites were used to compute the non-conversion rate
of unmodiﬁed cytosines upon bisulﬁte treatment. For the 5hmCG con-
trol, a ~1.64 kb region of the pUC19 vector was constructed by PCR am-
pliﬁcation with all cytosines being synthesized as 5hmCGs. These
5hmCG sites were used to evaluate the protection rate of 5hmCGs. For
this analysis, only cytosines in the CG contextwere considered (Supple-
mental Table 3). The TAB-Seq data set supporting the results of this ar-
ticle is available in NCBI GEO repository, accession number GSE70519.
For the data plotted in Fig. 5 and Supplemental Fig. 4, we grouped
genes into ﬁve quintile groups based on the ranking of expression levels
for ~18,000 transcripts in peripheral bloodmononuclear cells in a highly
cited previous study (Palmer et al., 2006). For each quintile (~3600 tran-
scripts), the level of 5hmCG was determined using weighted methyla-
tion level calculations (Schultz et al., 2012) for each of 20 bins
upstream, 20 bins within genes (between annotated TSS and TTS),
and 20 bins downstream of the gene region. Each of the upstream and
downstream bins spanned 5 kb of the total of 100 kb. The within-gene
regions, which varied in length, were evenly divided between the
20 bins. Figures were prepared using ggplot2 (Wickham, 2009).
A related analysis was used to investigate the level of the 5hmCG
marks in 100 bp windows in the context of transcriptionally- and
translationally-important locations: around the TSS, exon boundaries,
and around the TTS and in a larger window containing the collated
exons (i.e., seven genomic bins in all). For this analysis, numerous im-
mune cell-relevant GO terms were used. The genes in each GO term
set were extracted, and all CG sites within the bins were examined to
determine the level of 5hmCG. The total levels of 5hmCG in all leuko-
cytes were presented as box plots in order to show the variance in the
level of 5hmCG in each region. The weighted average of 5hmCG for
each cell type was also plotted as a colored dot within the diagram.
A table describing the GO terms used and the lists of genes is provid-
ed in Supplemental File 1. In order to determine the amount of
variance in 5hmCG levels explained by genomic bin, cell type, and
GO term set, an ANOVA was performed between the three factors
using R and the amount of variance explained by each factor was
determined by the proportion of their total sum of square
(Supplemental Fig. 6).
4.3. Fluorescent labeling of 5hmCG
Total white blood cells were isolated from both fresh (method
2) and frozen blood (method 3) (Fig. 4), ﬁxed with 3.7% formaldehyde
for 15min, and then centrifuged at 400 x g for 2min, afterwhich the su-
pernatantwas discarded. Cells were resuspended in 500 μl of 50%meth-
anol in PBS (phosphate buffered saline, pH 7.4), incubated for 1 min at
room temperature, and centrifuged at 400 ×g for 3 min, after which
the supernatant was discarded. Cells were heated to 95 °C for 5 min,
snap cooled on ice, washed two times with PBSBE (phosphate buffered
saline, 1% BSA, 2 mM EDTA, pH 7.4), and ﬁnally resuspended in 200 μlPBSBE and incubated for 45 min to block non-speciﬁc binding of anti-
bodies. Rabbit anti-5hmC polyclonal antibody (Active Motif, Carlsbad,
CA, USA Cat# 39769) was added to cells at a 1:200 dilution in PBSBE
and incubated at room temperature with rotation for 1 h. Cells were
washed three times with PBSBE and resuspended in 1:500 dilution of
goat anti-rabbit conjugated with phycoerythrin (PE) (Abcam, Cam-
bridge, MA, USA Cat# ab97070) in PBSBE and incubated at room tem-
perature with rotation in the dark for 1 h. Cells were washed three
times with PBSBE and ﬁnally resuspended in 30 μl of PBSBE. 10 μl of la-
beled cells were stainedwith 1 μl of DAPI (1mg/ml) for tenminutes and
examined with ﬂuorescence microscopy, all under the same exposure
conditions. Cells were classiﬁed by nuclear morphology into four
groups, round nuclei, kidney shaped nuclei, multilobed nuclei, or bi-
lobed nuclei, and Hamamatsu SimplePCI Image Analysis software was
used to assess the 5hmCG signal for at least 100 cells for each morphol-
ogy in each isolation method. Background ﬂuorescent was subtracted
from each raw 5hmCG signal. The 5hmGC signal for each of the mor-
phologies and each isolation method was divided into 4 quintiles of
data, labeled as minimal, low, medium or high 5hmCG signal. The cells
for each morphology were randomly separated into three groups and
the percent of cells falling in each 5hmCG signal range were identiﬁed
for each morphology in both isolation methods. To determine if there
was an interaction between the isolation method and the nuclear mor-
phology on the number of cells in each 5hmCG signal group a two-way
MANOVA was performed using Pillai trace test using SPSS software
(IBM). A signiﬁcant effect of only nuclear morphology was identiﬁed
and Bonferroni post-hoc analysis was used to assess differences be-
tween nuclear morphology and 5hmCG signal for this analysis with sig-
niﬁcance set at p b 0.05.4.4. qRT-PCR analysis of transcript levels
To assess the potential for turnover of 5mCG, three transcripts related
to DNAmethylation (DNMT1, 3A, and 3B) and six related to DNA demeth-
ylation (TET1, 2, 3 and GADD45A, B, G) were also assayed. Isolated leuko-
cytes bound to Dynabeads (Method 3, Order B) were washed in PBS and
frozen in liquid nitrogen and stored at−80 °C. RNA was extracted using
RNeasy Mini Kit (Qiagen, Frederick, MD, USA Cat# 74104) following the
manufacturer’s instructions. RNA concentrations were quantiﬁed using
the Qubit RNA assay kit (Life technologies, Grand Island, NY, USA Cat#
Q32855) and 400 ng of RNA was used for cDNA synthesis using qScript
cDNA synthesis supermix (Quanta Biosciences, Gaithersburg, MD, USA
Cat# 95148-100). Relative quantities (RQ) of cell type speciﬁc transcripts
were normalized to endogenous control ribosomal 18S rRNA
(Vandesompele et al., 2002) using the dCT method (Livak and
Schmittgen, 2001). We found beta-actinwas far more variably expressed
across the seven cell types than 18S rRNA, relative to a constant cDNA
input (Supplemental Fig. 7). Therefore, 18S rRNAwas used as an endoge-
nous controlwhen comparing transcripts related to establishment and re-
moval of 5mCG across cell types. 18S rRNA has the disadvantage as an
endogenous control that it is 1000-fold more abundant than any
mRNAs being assayed. Therefore, the low number of PCR cycles needed
to reach cycle threshold levels are far removed from those of the target,
which could be another source of error. Oligonucleotideprimer sequences
(Supplemental Table 2) were synthesized by Integrated DNA Technolo-
gies (Coralville, IA, USA). Two to six primer sets were tested for each of
the target genes and those having a single sharp dissociation peak, ensur-
ing the speciﬁc gene target was being ampliﬁed, and the lowest CT values
were selected for subsequent use. A 25 μl reaction using SYBR greenmas-
ter mix (Life Technologies, Grand Island, NY, USA Cat# 43677659) and
4 ng of cDNAwas used for analysis of the gene panel. To determine sta-
tistical relevance of differences in transcript levels, a one-way
ANOVA was used to examine the effects of cell type on expression
with Tukey's HSD test as a post hoc using Statistica software 7.1
(StatSoft; Tulsa, OK, USA).
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